Impact of diverticular inflammation and complication assessment classification on the burden of medical therapies in preventing diverticular disease complications in Italy.

摘要: Background: Several treatments are currently advised to manage diverticular disease (DD) patients, but their impact on the burden of is unknown. Our aim was assess economic analysis using recent Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification medical therapies prescribed in preventing DD complications occurrence Italy. Methods: We assessed retrospectively cost/year estimated DICA 1, 2 3 population. Analysis diverticulosis prevalence according data population provided by Italian Institute Statistics (ISTAT). Cost calculated drugs’ consumption collected during study. Results: that >8 million people >60 years may have diverticulosis, about 75% 30% 2, 13% 3. >387 euros could be spent 1 population, >203 >88 Since did not show any significant advantage when treating terms prevention acute diverticulitis occurrence/recurrence surgery occurrence, we can >475 Italy without benefit occurrence. Conclusions: a Italy, because it helps select who effectively need